Previously, the AKT1 rs3803304 polymorphism has been demonstrated to also influence susceptibility, disease progression or clinical outcome of head and neck squamous cell carcinoma, lung carcinoma and esophageal carcinoma, indicating its major functional and clinical implications. Here, AKT1 is linked to lung carcinoma.